John Haag was the chief operating partner of Presidio Partners in San
Francisco, California. Through Presidio Partners, he has worked with
Velocity Pharmaceuticals. “John has a unique ability to see into the
heart of issues and drive practical change,” said David Collier CEO of
Velocity Pharmaceuticals. He continued saying, “John’s excellent
attention to detail accompanied by the ability to see the “big picture”
makes John an excellent partner to company CEO’s and venture investors
alike.” Haag has been involved with the biotechnology industry on many
levels.
Biotechnology is a broad field that involves hundreds of
companies. The field focuses on the study of biological processes and
organisms. A major contributor to the biotechnology discipline is the
pharmaceutical industry. Pharmaceutical companies pour money into the
research and development of drugs and medicines. The pharmaceutical
industry does not just involve research, but marketing, business, and
finance as well. Pharmaceutical companies combine biotechnology with
many other industries.
The energy industry involves biotechnology as well. There are many companies that research new ways sources of
sustainable energy. These companies may focus on how to reduce the use
of water and other energy sources as well.
Food production
involves biotechnology as well. Scientists who work in biotechnology may
focus on increasing food production and farming efficiencies. They may
also develop food products that have a higher nutritional value. John Haag has worked with many companies that are involved with the
biotechnology discipline. He offers these companies his knowledge and
experience in finance, accounting, organization, and business
management.
